Post-Market Study of Alcon Intraocular Lenses

Clinical and Functional Performance of Acrysof IQ Vivity Versus Aspheric Monofocal IOLs

The purpose of the study is to evaluate clinical and functional performance in real-world conditions in participants who have been implanted with Acrysof IQ Vivity (Extended Vision) IOLs compared with Alcon Aspheric Monofocal IOLs.

This observational study will enroll subjects who have been implanted with an Alcon aspheric monofocal or monofocal toric IOL no less than 4 months prior to study procedures. This study will be conducted in Australia.

Key Inclusion Criteria:

• In good general health at the screening visit;
• Implanted in both eyes at least 4 months ago with either Vivity/Vivity toric IOL or an Alcon aspheric monofocal/monofocal toric IOL (Acrysof IQ/Clareon);
• Best Corrected Distance Visual Acuity (BCDVA) of 20/25 or better with both eyes together;
• BCDVA of 20/40 or better in each eye;

Key Exclusion Criteria:

• Clinically significant Posterior Capsular Opacity (PCO) as assessed via slit-lamp exam per investigator opinion;
• History of ocular surgery other than cataract surgery and Nd:YAG laser surgery;
• History of amblyopia.